Suven Life Sciences Announcements
Certificate under Reg. 74(5)
09 Oct, 2025 | 01:26pm • Source: BSE
Please find enclosed News Release of our company in relation to Q1 FY 2025-26 Financial Results.
13 Aug, 2025 | 03:01pm • Source: BSE
Financial Results Q1 FY 2025-26
13 Aug, 2025 | 12:52pm • Source: BSE
Suven Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider...
05 Aug, 2025 | 04:03pm • Source: BSE
Please find enclosed BRSR FY 2024-25
30 Jul, 2025 | 02:01pm • Source: BSE
Notice of 36th Annual General Meeting
30 Jul, 2025 | 01:59pm • Source: BSE
Annual Report 2024-25 and Notice of 36th Annual General Meeting (AGM) of the Company
30 Jul, 2025 | 01:43pm • Source: BSE
Allotment of 2,14,000 Equity Shares upon exercise of vested options under SLSL ESOP 2020
24 Jul, 2025 | 03:56pm • Source: BSE
Allotment of 91,86,490 Equity Shares of the Company on preferential basis upon conversion 91,86,490 fully paid warrants
16 Jul, 2025 | 02:54pm • Source: BSE
Please find enclosed News Release of our company
16 Jul, 2025 | 01:01pm • Source: BSE
Certificates for quarter ended 30th June, 2025
09 Jul, 2025 | 10:58am • Source: BSE
The Board of Directors of the Company in its meeting held today i.e. 03rd July, 2025 has allotted convertible Warrants to 23 allottees.
03 Jul, 2025 | 04:57pm • Source: BSE
Scrutinizers report for EGM held on 05th June 2025
05 Jun, 2025 | 04:11pm • Source: BSE
Outcome of the EGM held on 05th June, 2025
05 Jun, 2025 | 04:09pm • Source: BSE
Additional Disclosure in the Notice of EGM
04 Jun, 2025 | 07:17pm • Source: BSE
Corrigendum to Notice of the Extra-Ordinary General Meeting to be held on 05th June, 2025
28 May, 2025 | 04:12pm • Source: BSE
Annual Secretarial Compliance Report for year ended 31/03/2025
22 May, 2025 | 02:36pm • Source: BSE
Newspaper Advertisement - EGM Notice
15 May, 2025 | 03:14pm • Source: BSE